Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Botox plus physiotherapy for post-stroke upper limb spasticity
2010-021257-39Phase 2Completed
- Sponsor
- Sandwell and West Birmingham NHS Trust
- Start
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of botulinum toxin type A in poststroke spasticity (PSS) and stroke (2 arms), sponsored by Sandwell and West Birmingham NHS Trust. Primary endpoints: Arm function at 3 months post injection and Arm function at 6 months post stroke. Started Jun 2011; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
poststroke spasticity (PSS)stroke
Beyond the preview
Go deeper on 2010-021257-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021257-39.